Latent Autoimmune Diabetes of Adults

It's an autoimmune form of diabetes that's comparable to T1D, but patients with LADA often have insulin resistance, which is similar to T2D, and they share several risk factors for the illness. According to studies, LADA patients develop antibodies against insulin-producing cells, and these cells quit releasing insulin at a slower rate than T1D patients. T1D and T2D appear to have genetic risk factors in common, although LADA is genetically separate from both. There is genetic and phenotypic heterogeneity within the LADA patient population, with variable degrees of insulin resistance and autoimmunity. LADA can thus be regarded as a hybrid type of T1D and T2D, with clinical and genotypic parallels to both, as well as variance within LADA in terms of autoimmunity and insulin resistance, based on current information.

    Related Conference of Latent Autoimmune Diabetes of Adults

    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Paris, France
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    April 14-15, 2025

    6th Global Summit on Environmental Health

    Amsterdam, Netherlands
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Latent Autoimmune Diabetes of Adults Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in